{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:26:05Z","timestamp":1789025165003,"version":"build-2803163510"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04404-7","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T05:32:01Z","timestamp":1768368721000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Using transcriptomics and molecular docking to uncover the pharmacological targets and its associated biological mechanisms of paeoniflorigenone in treating bladder cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Tianyu","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"4404_CR1","first-page":"S33","volume":"551","author":"M Grayson","year":"2017","unstructured":"Grayson M. Bladder. Cancer Nat. 2017;551:S33.","journal-title":"Cancer Nat"},{"key":"4404_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.5644\/ama2006-124.332","volume":"50","author":"M Ulamec","year":"2021","unstructured":"Ulamec M, Murgi\u0107 J, Novosel L, Tomi\u0107 M, Terlevi\u0107 R, Toma\u0161kovi\u0107 I, Jazvi\u0107 M, Froebe A, Kru\u0161lin B. New insights into the diagnosis, molecular taxonomy, and treatment of bladder cancer. Acta Med Academica. 2021;50:143\u201356.","journal-title":"Acta Med Academica"},{"key":"4404_CR3","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.euf.2020.01.007","volume":"6","author":"G Gakis","year":"2020","unstructured":"Gakis G. Management of Muscle-invasive bladder cancer in the 2020s: challenges and perspectives. Eur Urol Focus. 2020;6:632\u20138.","journal-title":"Eur Urol Focus"},{"key":"4404_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/14728214.2018.1474201","volume":"23","author":"J Crijnen","year":"2018","unstructured":"Crijnen J, De Reijke TM. Emerging intravesical drugs for the treatment of Non muscle-invasive bladder cancer. Expert Opin Emerg Drugs. 2018;23:135\u201347.","journal-title":"Expert Opin Emerg Drugs"},{"key":"4404_CR5","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.pharmthera.2021.107843","volume":"225","author":"K Huang","year":"2021","unstructured":"Huang K, Zhang P, Zhang Z, Youn JY, Wang C, Zhang H, Cai H. Traditional Chinese medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms. Pharmacol Ther. 2021;225:107843.","journal-title":"Pharmacol Ther"},{"key":"4404_CR6","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/S0140-6736(08)61354-9","volume":"372","author":"JL Tang","year":"2008","unstructured":"Tang JL, Liu BY, Ma KW. Traditional Chinese medicine. Lancet (London England). 2008;372:1938\u201340.","journal-title":"Lancet (London England)"},{"key":"4404_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13020-022-00657-w","volume":"17","author":"Q Ye","year":"2022","unstructured":"Ye Q, Zhang Y, Yan D, Sun Y, Li M, Cao H, Wang S, Meng J. Integrating pharmacokinetics and network analysis to investigate the mechanism of Moutan cortex in blood-heat and blood stasis syndrome. Chin Med. 2022;17:107.","journal-title":"Chin Med"},{"key":"4404_CR8","first-page":"207279","volume":"2013","author":"MY Lin","year":"2013","unstructured":"Lin MY, Lee YR, Chiang SY, Li YZ, Chen YS, Hsu CD, Liu YW. Cortex Moutan induces bladder cancer cell death via apoptosis and retards tumor growth in mouse bladders. Evid Based Complement Altern Med eCAM. 2013;2013:207279.","journal-title":"Evid Based Complement Altern Med eCAM"},{"key":"4404_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1021\/np9704258","volume":"61","author":"HC Lin","year":"1998","unstructured":"Lin HC, Ding HY, Wu YC. Two novel compounds from paeonia suffructicosa. J Nat Prod. 1998;61:343\u20136.","journal-title":"J Nat Prod"},{"key":"4404_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1080\/09168451.2017.1300517","volume":"81","author":"Y Huang","year":"2017","unstructured":"Huang Y, Ohno O, Suenaga K, Miyamoto K. Apoptosis-inducing activity and antiproliferative effect of paeoniflorigenone from Moutan cortex. Biosci Biotechnol Biochem. 2017;81:1106\u201313.","journal-title":"Biosci Biotechnol Biochem"},{"key":"4404_CR11","doi-asserted-by":"publisher","first-page":"115000","DOI":"10.1016\/j.jep.2022.115000","volume":"288","author":"KR Park","year":"2022","unstructured":"Park KR, Lee H, Kim SH, Yun HM. Paeoniflorigenone regulates apoptosis, autophagy, and necroptosis to induce anti-cancer bioactivities in human head and neck squamous cell carcinomas. J Ethnopharmacol. 2022;288:115000.","journal-title":"J Ethnopharmacol"},{"key":"4404_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3724\/SP.J.1009.2013.00110","volume":"11","author":"S Li","year":"2013","unstructured":"Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med. 2013;11:110\u201320.","journal-title":"Chin J Nat Med"},{"key":"4404_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","volume":"43","author":"C Nogales","year":"2022","unstructured":"Nogales C, Mamdouh ZM, List M, Kiel C, Casas AI, Schmidt H. Network pharmacology: curing causal mechanisms instead of treating symptoms. Trends Pharmacol Sci. 2022;43:136\u201350.","journal-title":"Trends Pharmacol Sci"},{"key":"4404_CR14","doi-asserted-by":"publisher","first-page":"106758","DOI":"10.1016\/j.intimp.2020.106758","volume":"86","author":"AA El-Arabey","year":"2020","unstructured":"El-Arabey AA, Abdalla M, Abd-Allah AR. SnapShot: TP53 status and macrophages infiltration in TCGA-analyzed tumors. Int Immunopharmacol. 2020;86:106758.","journal-title":"Int Immunopharmacol"},{"key":"4404_CR15","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1021\/acsomega.2c07619","volume":"8","author":"IM Kamal","year":"2023","unstructured":"Kamal IM, Chakrabarti S. MetaDOCK: a combinatorial molecular docking approach. ACS Omega. 2023;8:5850\u201360.","journal-title":"ACS Omega"},{"key":"4404_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/bs.pmch.2021.01.004","volume":"60","author":"F Stanzione","year":"2021","unstructured":"Stanzione F, Giangreco I, Cole JC. Use of molecular docking computational tools in drug discovery. Prog Med Chem. 2021;60:273\u2013343.","journal-title":"Prog Med Chem"},{"key":"4404_CR17","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS. TIMER: a web server for comprehensive analysis of Tumor-Infiltrating immune cells. Cancer Res. 2017;77:e108\u201310.","journal-title":"Cancer Res"},{"key":"4404_CR18","first-page":"1779","volume":"12","author":"ANS Shamsol Azman","year":"2023","unstructured":"Shamsol Azman ANS, Tan JJ, Abdullah MNH, Bahari H, Lim V, Yong YK. Network Pharmacology and molecular docking analysis of active compounds in Tualang honey against atherosclerosis. Foods (Basel Switzerland). 2023;12:1779.","journal-title":"Foods (Basel Switzerland)"},{"key":"4404_CR19","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71:209\u201349.","journal-title":"Cancer J Clin"},{"key":"4404_CR20","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/pharmaceutics15041117","volume":"15","author":"Y Kang","year":"2023","unstructured":"Kang Y, Park C, Lee H, Kang S, Cheon C, Kim B. Natural products as new approaches for treating bladder cancer: from traditional medicine to novel drug discovery. Pharmaceutics. 2023;15:1117.","journal-title":"Pharmaceutics"},{"key":"4404_CR21","first-page":"7178414","volume":"2021","author":"S Zhou","year":"2021","unstructured":"Zhou S, Fan X, Du X, Liu S, Sun H, Zhang Y. Effect of Traditional Chinese Medicine combined with bladder perfusion with hydroxycamptothecin on color ultrasound and clinical efficacy in patients with bladder cancer surgery. Evid Based Complement Altern Med eCAM. 2021;2021:7178414.","journal-title":"Evid Based Complement Altern Med eCAM"},{"key":"4404_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.canlet.2016.04.034","volume":"377","author":"M Liu","year":"2016","unstructured":"Liu M, Hu Y, Zhang MF, Luo KJ, Xie XY, Wen J, Fu JH, Yang H. MMP1 promotes tumor growth and metastasis in esophageal squamous cell carcinoma. Cancer Lett. 2016;377:97\u2013104.","journal-title":"Cancer Lett"},{"key":"4404_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s41021-017-0074-z","volume":"39","author":"AA El-Arabey","year":"2017","unstructured":"El-Arabey AA. New insight for Metformin against bladder cancer. Genes Environment: Official J Japanese Environ Mutagen Soc. 2017;39:13.","journal-title":"Genes Environment: Official J Japanese Environ Mutagen Soc"},{"key":"4404_CR24","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1158\/1535-7163.MCT-15-0140","volume":"14","author":"K Yuge","year":"2015","unstructured":"Yuge K, Kikuchi E, Hagiwara M, Yasumizu Y, Tanaka N, Kosaka T, Miyajima A, Oya M. Nicotine induces tumor growth and chemoresistance through activation of the PI3K\/Akt\/mTOR pathway in bladder cancer. Mol Cancer Ther. 2015;14:2112\u201320.","journal-title":"Mol Cancer Ther"},{"key":"4404_CR25","doi-asserted-by":"publisher","first-page":"e24719","DOI":"10.1002\/jcla.24719","volume":"36","author":"X Xu","year":"2022","unstructured":"Xu X, Lu X, Chen L, Peng K, Ji F. Downregulation of MMP1 functions in preventing perineural invasion of pancreatic cancer through blocking the NT-3\/TrkC signaling pathway. J Clin Lab Anal. 2022;36:e24719.","journal-title":"J Clin Lab Anal"},{"key":"4404_CR26","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.2174\/1386207323666200917103253","volume":"24","author":"C Shen","year":"2021","unstructured":"Shen C, Da L, Wu Z, Wang Y, Gao S, Tian D, Hu H. Expression and prognostic significance of the MMP family molecules in bladder cancer. Comb Chem High Throughput Screen. 2021;24:1183\u201396.","journal-title":"Comb Chem High Throughput Screen"},{"key":"4404_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.clinbiochem.2021.03.003","volume":"92","author":"HY Liao","year":"2021","unstructured":"Liao HY, Da CM, Liao B, Zhang HH. Roles of matrix metalloproteinase-7 (MMP-7) in cancer. Clin Biochem. 2021;92:9\u201318.","journal-title":"Clin Biochem"},{"key":"4404_CR28","first-page":"48","volume":"11","author":"T Szarvas","year":"2020","unstructured":"Szarvas T, Hoffmann MJ, Olah C, Szekely E, Kiss A, Hess J, Tschirdewahn S, Hadaschik B, Grotheer V, Nyirady P, Csizmarik A, Varadi M, Reis H. MMP-7 serum and tissue levels are associated with poor survival in platinum-treated bladder cancer patients. Diagnostics (Basel Switzerland). 2020;11:48.","journal-title":"Diagnostics (Basel Switzerland)"},{"key":"4404_CR29","doi-asserted-by":"publisher","first-page":"112260","DOI":"10.1016\/j.ejmech.2020.112260","volume":"194","author":"S Mondal","year":"2020","unstructured":"Mondal S, Adhikari N, Banerjee S, Amin SA, Jha T. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview. Eur J Med Chem. 2020;194:112260.","journal-title":"Eur J Med Chem"},{"key":"4404_CR30","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3390\/biomedicines11030956","volume":"11","author":"J Kudelski","year":"2023","unstructured":"Kudelski J, Tokarzewicz A, Gudowska-Sawczuk M, Mroczko B, Ch\u0142osta P, Bruczko-Goralewska M, Mitura P, M\u0142ynarczyk G. The significance of matrix metalloproteinase 9 (MMP-9) and metalloproteinase 2 (MMP-2) in urinary bladder cancer. Biomedicines. 2023;11:956.","journal-title":"Biomedicines"},{"key":"4404_CR31","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/j.cellsig.2012.04.013","volume":"24","author":"SJ Lee","year":"2012","unstructured":"Lee SJ, Lim JH, Choi YH, Kim WJ, Moon SK. Interleukin-28A triggers wound healing migration of bladder cancer cells via NF-\u03baB-mediated MMP-9 expression inducing the MAPK pathway. Cell Signal. 2012;24:1734\u201342.","journal-title":"Cell Signal"},{"key":"4404_CR32","first-page":"3162","volume":"16","author":"T Li","year":"2018","unstructured":"Li T, Xu K, Liu Y. Anticancer effect of Salidroside reduces viability through autophagy\/PI3K\/Akt and MMP-9 signaling pathways in human bladder cancer cells. Oncol Lett. 2018;16:3162\u20138.","journal-title":"Oncol Lett"},{"key":"4404_CR33","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.18632\/aging.204599","volume":"15","author":"X Zhang","year":"2023","unstructured":"Zhang X, Deng Q, Wan X, Zhao J, Zheng X, Wang H, Wang HQ, Yang W. Pan-cancer analysis reveals the associations between MMP13 high expression and carcinogenesis and its value as a serum diagnostic marker. Aging. 2023;15:2115\u201335.","journal-title":"Aging"},{"key":"4404_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/1097-0215(20001101)88:3<417::AID-IJC14>3.0.CO;2-G","volume":"88","author":"PJ Bostr\u00f6m","year":"2000","unstructured":"Bostr\u00f6m PJ, Ravanti L, Reunanen N, Aaltonen V, S\u00f6derstr\u00f6m KO, K\u00e4h\u00e4ri VM, Laato M. Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int J Cancer. 2000;88:417\u201323.","journal-title":"Int J Cancer"},{"key":"4404_CR35","doi-asserted-by":"publisher","first-page":"991","DOI":"10.3390\/cells8090991","volume":"8","author":"J Gonzalez-Molina","year":"2019","unstructured":"Gonzalez-Molina J, Gramolelli S, Liao Z, Carlson JW, Ojala PM, Lehti K. MMP14 in sarcoma: a regulator of tumor microenvironment communication in connective tissues. Cells. 2019;8:991.","journal-title":"Cells"},{"key":"4404_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s13277-014-2747-6","volume":"36","author":"E Wieczorek","year":"2015","unstructured":"Wieczorek E, Jablonska E, Wasowicz W, Reszka E. Matrix metalloproteinases and genetic mouse models in cancer research: a mini-review. Tumour Biology: J Int Soc Oncodevelopmental Biology Med. 2015;36:163\u201375.","journal-title":"Tumour Biology: J Int Soc Oncodevelopmental Biology Med"},{"key":"4404_CR37","first-page":"6605","volume":"24","author":"JF Wang","year":"2020","unstructured":"Wang JF, Gong YQ, He YH, Ying WW, Li XS, Zhou XF, Zhou LQ. High expression of MMP14 is associated with progression and poor short-term prognosis in muscle-invasive bladder cancer. Eur Rev Med Pharmacol Sci. 2020;24:6605\u201315.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4404_CR38","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1021\/acs.jproteome.0c00239","volume":"19","author":"J Yuan","year":"2020","unstructured":"Yuan J, Yi K, Yang L. TGFBR2 regulates Hedgehog pathway and cervical cancer cell proliferation and migration by mediating SMAD4. J Proteome Res. 2020;19:3377\u201385.","journal-title":"J Proteome Res"},{"key":"4404_CR39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s10020-019-0111-4","volume":"25","author":"Q Liu","year":"2019","unstructured":"Liu Q, Guo L, Zhang S, Wang J, Lin X, Gao F. PRSS1 mutation: a possible pathomechanism of pancreatic carcinogenesis and pancreatic cancer. Mol Med (Cambridge Mass). 2019;25:44.","journal-title":"Mol Med (Cambridge Mass)"},{"key":"4404_CR40","doi-asserted-by":"publisher","first-page":"11161","DOI":"10.1038\/s41598-022-15205-7","volume":"12","author":"X Wang","year":"2022","unstructured":"Wang X, Wang J, Lyu L, Gao X, Cai Y, Tang B. Oncogenic role and potential regulatory mechanism of topoisomerase II\u03b1 in a pan-cancer analysis. Sci Rep. 2022;12:11161.","journal-title":"Sci Rep"},{"key":"4404_CR41","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1002\/2211-5463.12964","volume":"10","author":"T Jiang","year":"2020","unstructured":"Jiang T, Lu X, Yang F, Wang M, Yang H, Xing N. LMTK3 promotes tumorigenesis in bladder cancer via the ERK\/MAPK pathway. FEBS Open Bio. 2020;10:2107\u201321.","journal-title":"FEBS Open Bio"},{"key":"4404_CR42","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/978-3-030-38315-2_4","volume":"1240","author":"RM Gorczynski","year":"2020","unstructured":"Gorczynski RM. IL-17 signaling in the tumor microenvironment. Adv Exp Med Biol. 2020;1240:47\u201358.","journal-title":"Adv Exp Med Biol"},{"key":"4404_CR43","doi-asserted-by":"publisher","first-page":"804347","DOI":"10.1155\/2015\/804347","volume":"2015","author":"T Welte","year":"2015","unstructured":"Welte T, Zhang XH. Interleukin-17 could promote breast cancer progression at several stages of the disease. Mediat Inflamm. 2015;2015:804347.","journal-title":"Mediat Inflamm"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04404-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04404-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04404-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:02:59Z","timestamp":1770652979000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04404-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4404"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04404-7","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"1 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"270"}}